pd 128907 has been researched along with apomorphine in 3 studies
Studies (pd 128907) | Trials (pd 128907) | Recent Studies (post-2010) (pd 128907) | Studies (apomorphine) | Trials (apomorphine) | Recent Studies (post-2010) (apomorphine) |
---|---|---|---|---|---|
9 | 0 | 4 | 9,205 | 287 | 780 |
16 | 0 | 9 | 9,205 | 287 | 780 |
Protein | Taxonomy | pd 128907 (IC50) | apomorphine (IC50) |
---|---|---|---|
Tryptophan 5-hydroxylase 1 | Rattus norvegicus (Norway rat) | 0.22 | |
D(2) dopamine receptor | Homo sapiens (human) | 0.0146 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 7.75 | |
D | Rattus norvegicus (Norway rat) | 0.4744 | |
D(3) dopamine receptor | Rattus norvegicus (Norway rat) | 0.1432 | |
Alpha-2B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.063 | |
D(2) dopamine receptor | Bos taurus (cattle) | 0.3385 | |
D(1A) dopamine receptor | Homo sapiens (human) | 0.025 | |
D(4) dopamine receptor | Homo sapiens (human) | 0.025 | |
D(1B) dopamine receptor | Homo sapiens (human) | 0.025 | |
Alpha-2C adrenergic receptor | Rattus norvegicus (Norway rat) | 0.063 | |
Alpha-2A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.063 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 7.75 | |
D(1B) dopamine receptor | Rattus norvegicus (Norway rat) | 0.1432 | |
D(4) dopamine receptor | Rattus norvegicus (Norway rat) | 0.1432 | |
D(3) dopamine receptor | Homo sapiens (human) | 0.025 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 7.75 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 0.0813 | |
E3 ubiquitin-protein ligase Mdm2 | Homo sapiens (human) | 0.205 | |
5-hydroxytryptamine receptor 4 | Rattus norvegicus (Norway rat) | 1.35 | |
D | Bos taurus (cattle) | 0.3385 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 2 (66.67) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
DeWald, HA; Heffner, TG; Jaen, JC; Lustgarten, DM; McPhail, AT; Meltzer, LT; Pugsley, TA; Wise, LD | 1 |
Griffon, N; Lévesque, D; Pilon, C; Sautel, F; Schwartz, JC; Sokoloff, P | 1 |
Dijkstra, D; Horn, AS; Mulder, TB; Rollema, H; Tepper, PG; Van der Weide, J | 1 |
3 other study(ies) available for pd 128907 and apomorphine
Article | Year |
---|---|
Synthesis and dopamine agonist properties of (+-)-trans-3,4,4a,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano [4,3-b]-1,4-oxazin-9-ol and its enantiomers.
Topics: Animals; Benzopyrans; Cell Membrane; Chemical Phenomena; Chemistry; Corpus Striatum; Dihydroxyphenylalanine; Dopamine; Dopamine Agents; Electrophysiology; Haloperidol; Male; Mice; Molecular Structure; Motor Activity; Neurons; Oxazines; Rats; Receptors, Dopamine; Receptors, Dopamine D2; Stereoisomerism; Substantia Nigra | 1990 |
A functional test identifies dopamine agonists selective for D3 versus D2 receptors.
Topics: Animals; CHO Cells; Cricetinae; Dopamine Agents; Humans; Receptors, Dopamine; Receptors, Dopamine D2; Receptors, Dopamine D3 | 1995 |
Synthesis and pharmacology of trans-4-n-propyl-3,4,4a,10b-tetrahydro-2H,5H-1-benzopyrano[4,3-b ]-1,4-oxazin-7- and -9-ols: the significance of nitrogen pKa values for central dopamine receptor activation.
Topics: Animals; Benzopyrans; Binding Sites; Brain Chemistry; Cattle; Dopamine; Dopamine Agents; Nitrogen; Oxazines; Protons; Rats; Receptors, Dopamine | 1988 |